Breast cancer and other neoplasms in women with neurofibromatosis type 1: A retrospective review of cases in the Detroit metropolitan area

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 12, 2012, Pages 3061-3064

  Wang, X ^a   Levin, A M ^a   Smolinski, S E ^b   Vigneau, F D ^b   Levin, N K ^b   Tainsky, M A ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Hereditary cancer risk; Hereditary cancer syndrome; Neurofibromatosis type 1; Neurofibromin; NF1 gene

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NEOPLASM; NEUROFIBROMATOSIS; ONSET AGE; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; STANDARDIZED INCIDENCE RATIO; UNITED STATES;

EID: 84870247655     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35560     Document Type: Article

References (11)

1. Brems H, Beert E, De Ravel T, Legius E. 2009. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10: 508-515.
2. Martuza RL, Eldridge R. 1988. Neurofibromatosis conference statement: National Institute of Health consensus development conference. Arch Neurol 45: 575-578.
3. Rasmussen SA, Yang Q, Friedman JM. 2001. Mortality in neurofibromatosis 1: An analysis using U.S. death certificate. Am J Hum Genet 68: 1110-1118.
4. Rebollo A, Matrinez-A C. 1999. Ras protein: Recent advances and new functions. Blood 94: 2971-2980.
5. Safali GS, Guran S. 2005. A case of neurofibromatosis and breast cancer: Loss of heterozygosity of NF1 in breast cancer. Cancer Genet Cytogenet 156: 86-88.
6. Salemis NS, Nakos G, Sambaziotis D, Gourgiotis S. 2001. Breast cancer associated with type 1 neurofibromatosis. Breast Cancer 17: 306-309.
7. Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DGR. 2007. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44: 481-484.
8. Sørensen SA, Mulvihill JJ, Nielsen A. 1986. Long-term follow-up of von Recklinghausen neurofibromatosis-Survival and malignant neoplasms. N Engl J Med 314: 1010-1015.
9. Viskochil D. 2005. Neurofibromatosis type 1. In: Cassidy SB, Allanson JE, editors Management of genetic syndromes, 2e. New York: Wiley-Liss. pp 369-384.
10. Walker L, Thompsone D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D. 2006. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 95: 233-238.
11. Zöller ME, Rembeck B, Odén A, Samuelsson M, Angervall L. 1997. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79: 2125-2131.